Clinical Trial Update: NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial is evaluating NK cell infusions in combination with irinotecan, temozolomide, and dinutuximab for relapsed or refractory neu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Irinotecan (Irinotecan)
• Natural killer (NK) cell infusion (natural killer cells)
• Temozolomide (Temozolomide)
• dinutuximab (dinutuximab)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Relapsed Neuroblastoma, Refractory Neuroblastoma | Phase 1, Phase 2 | Status: RECRUITING